[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today

Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today

BLCO : 16.23 (-2.99%)
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate

Phase 2 study did not meet its primary endpoint. Company will discontinue development of eye drops for glaucoma-related vision improvement but continue pursuing a sustained-release implant...

BLCO.TO : 22.89 (-3.50%)
BLCO : 16.23 (-2.99%)
Bausch + Lomb Introduces Orphiaâ„¢, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care

Designed to reduce the operational burden that stands between physicians and their patients. Initial offering focuses on pre-surgery cataract education, with additional AI capabilities...

BLCO.TO : 22.89 (-3.50%)
BLCO : 16.23 (-2.99%)
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July...

BLCO.TO : 22.89 (-3.50%)
BLCO : 16.23 (-2.99%)
1 Unpopular Stock That Deserves a Second Chance and 2 We Brush Off

1 Unpopular Stock That Deserves a Second Chance and 2 We Brush Off

BLCO : 16.23 (-2.99%)
HLIO : 80.03 (-0.22%)
SYBT : 76.26 (+0.58%)
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence

Among dry eye sufferers who said their stress or anxiety levels were affected, most (73%) reported improvement following treatment While some sufferers (22%) were aware that dry eye symptoms...

BLCO.TO : 22.89 (-3.50%)
BLCO : 16.23 (-2.99%)
3 Small-Cap Stocks We Steer Clear Of

3 Small-Cap Stocks We Steer Clear Of

ASAN : 7.33 (-0.54%)
RIG : 5.20 (+1.17%)
BLCO : 16.23 (-2.99%)
1 Stock Under $50 to Own for Decades and 2 We Turn Down

1 Stock Under $50 to Own for Decades and 2 We Turn Down

DKNG : 26.48 (+0.70%)
FOUR : 50.81 (+3.08%)
BLCO : 16.23 (-2.99%)
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

Blink Triple Care Preservative Free eye drops are made with the same clinically proven formula as Blink Triple Care and provide up to 10 hours of dry eye symptom relief‡ ...

BLCO.TO : 22.89 (-3.50%)
BLCO : 16.23 (-2.99%)
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Chief Medical...

BLCO.TO : 22.89 (-3.50%)
BLCO : 16.23 (-2.99%)

Barchart Exclusives

The $6 Billion Reason Vodafone Stock Is Up Today
Vodafone stock soars as e& sells stake to Vega. Here’s what the announcement means for VOD shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.